Sanofi has appointed Paulo Fontoura as Executive Vice President and Global Head of Research & Development Pharma, effective September 1. Based in Paris, Fontoura will join the Executive Committee and report to CEO Belen Garijo, overseeing the company's end-to-end innovation engine from research through regulatory affairs. He succeeds Dr. Houman Ashrafian, who is leaving the company. The appointment comes as Sanofi drives an R&D transformation and advances a pipeline of new medicines across multiple therapeutic areas.
Sanofi SAAppointment of new R&D head signals strategic focus on pipeline, but impact on near-term outcomes is unclear
MacroGenics Inc